Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q2
Sell
-100,341
Closed -$405K 2823
2024
Q1
$405K Hold
100,341
﹤0.01% 2340
2023
Q4
$561K Sell
100,341
-1,182
-1% -$6.79K ﹤0.01% 2287
2023
Q3
$541K Buy
101,523
+20,580
+25% +$167K ﹤0.01% 2261
2023
Q2
$700K Hold
80,943
﹤0.01% 2171
2023
Q1
$700K Buy
80,943
+5,894
+8% +$52K ﹤0.01% 2171
2022
Q4
$531K Buy
75,049
+10,977
+17% +$92.1K ﹤0.01% 2158
2022
Q3
$636K Sell
64,072
-3,528
-5% -$31.9K ﹤0.01% 2229
2022
Q2
$483K Buy
+67,600
New +$493K ﹤0.01% 2331

Other funds holding DCGO

UBS AM's DCGO Position: Q2 2024 in Review

UBS AM sold out of DocGo (DCGO) in Q2 2024, closing a stake of 100,341 shares — an estimated $405K sold.

UBS AM first reported a position in DCGO in Q2 2022 and held it in 8 quarters. The position peaked at $700K in Q2 2023. 123 funds tracked by Wall St. Rank hold DCGO as of Q2 2024.

  • UBS AM reported no remaining DocGo position as of Q2 2024 after selling out during the quarter.
  • UBS AM sold 100,341 DocGo shares in Q2 2024, an estimated $405K.
  • UBS AM first reported a position in DocGo in Q2 2022 and held it in 8 quarters.
  • UBS AM's DocGo position peaked at $700K in Q2 2023.
  • 123 funds tracked by Wall St. Rank held DocGo as of Q2 2024.

Based on UBS AM's 13F filing for Q2 2024, filed 14 Aug 2024.